Cargando…
C-Type Natriuretic Peptide in Essential Hypertension: Old Ways for a New Time
Multiple mechanisms are involved in essential hypertension. Antihypertensive drugs mainly target increased activity of the sympathetic nervous system, altered production of vasoactive mediators, vascular inflammation, fibrosis, and increased peripheral resistance. C-type natriuretic peptide (CNP) is...
Autores principales: | Perunovic, Tara, Goetze, Jens P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10264563/ https://www.ncbi.nlm.nih.gov/pubmed/37325397 http://dx.doi.org/10.1016/j.jacbts.2023.02.007 |
Ejemplares similares
-
Von Willebrand Factor Activity in Thrombosis: An Overlooked Target for Intervention?
por: Shalmi, Theodor W., et al.
Publicado: (2021) -
Associations of plasma atrial natriuretic peptide and electrolyte levels with essential hypertension
por: HU, GUANGMEI, et al.
Publicado: (2013) -
A State of Natriuretic Peptide Deficiency
por: Nyberg, Michael, et al.
Publicado: (2022) -
Pharmacological agents modifying the renin angiotensin and natriuretic peptide systems in COVID-19 patients
por: Vitiello, Antonio, et al.
Publicado: (2021) -
Cardiac natriuretic peptides in plasma increase after dietary induced weight loss in obesity
por: Kistorp, Caroline, et al.
Publicado: (2014)